The Effect of Tiotropium/Olodaterol versus Salmeterol/Fluticasone on Left Ventricular Function and Lung Hyperinflation in Patients with COPD

被引:0
|
作者
Herth, F. J. [1 ]
Hohlfeld, J. M. [2 ]
Haas, J. [3 ]
de la Hoz, A. [4 ]
Jin, X. [5 ]
Kreitner, K. [6 ]
Vogelmeier, C. F. [7 ]
Vogel-Claussen, J. [8 ]
Watz, H. [9 ]
机构
[1] Thoraxklin Heidelberg GmbH, Heidelberg, Germany
[2] German Ctr Lung Res DZL, Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany
[3] CIMS Studienzentrum Bamberg GmbH, Bamberg, Germany
[4] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Johannes Gutenberg Univ Mainz, Dept Radiol, Mainz, Germany
[7] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, German Ctr Lung Res DZL, Marburg, Germany
[8] Hannover Med Sch, Diagnost & Intervent Radiol, Hannover, Germany
[9] LungenClin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3308
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Tiotropium plus olodaterol provides significant lung-function benefits compared to fluticasone plus salmeterol regardless of prior bronchodilator use
    Derom, Eric
    Beeh, Kai-Michael
    Echave-Sustaeta, Jose
    Gronke, Lars
    Zhai, Dongmei
    Bjermer, Leif
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [12] Effect of Fluticasone/Salmeterol on Sleep Quality in Patients with COPD
    Banta, E. M.
    Mende, C.
    Rhoads, C.
    Craig, T. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB43 - AB43
  • [13] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Buhl, Roland
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 51 - 51
  • [14] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Bai, Chunxue
    Buhl, Roland
    Lee, Sang Haak
    Lee, Kwan Ho
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 53 - 53
  • [15] Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot study
    Bateman, E. D.
    van Dyk, M.
    Sagriotis, A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (01) : 20 - 25
  • [16] The comparison for the effects of triple therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in patients of COPD combined with asthma
    Keun, Rhee Yang
    Ri, Kirn Su
    Chul, Lee Yong
    Bum, Lee Heung
    Ju, Park Seoung
    Iiee, Moon
    WORLD ALLERGY CONGRESS (WAC), 2009, : 33 - 37
  • [17] Once-Daily Qva149 Provides Clinically Meaningful Improvements In Lung Function And Clinical Outcomes Versus Placebo, Indacaterol, Glycopyrronium, Tiotropium And Salmeterol/fluticasone In Patients With COPD
    Vogelmeier, C.
    Dahl, R.
    D'Urzo, T.
    Chen, H.
    Green, Y.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [18] Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
    Banerji, Donald
    Patalano, Francesco
    RESPIRATORY MEDICINE, 2016, 110 : 79 - 80
  • [19] Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
    Donohue, James F.
    Worsley, Sally
    Zhu, Chang-Qing
    Hardaker, Liz
    Church, Alison
    RESPIRATORY MEDICINE, 2015, 109 (07) : 870 - 881
  • [20] Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD
    Dransfield, Mark T.
    Cockcroft, John R.
    Townsend, Raymond R.
    Coxson, Harvey O.
    Sharma, Sanjay S.
    Rubin, David B.
    Emmett, Amanda H.
    Cicale, Michael J.
    Crater, Glenn D.
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2011, 105 (09) : 1322 - 1330